Blog

Oct 31, 2024, 14:31

Development of TLS in different tumor sites from patients with high-grade serous ovarian cancer – Cancer Research Institute

Cancer Research Institute shared a post on LinkedIn:

“Aiming to improve the understanding of immune cell organization in ovarian cancer, a new study from researchers including CRI-Irvington Postdoctoral Fellow Dr. Ayana Ruffin of Emory University and former CRI-V Foundation CLIP Investigator Dr. Tullia Bruno of University of Pittsburgh sheds light on the development of tertiary lymphoid structures (TLS) in different tumor sites from patients with high-grade serous ovarian cancer.

Explore their findings, and discover how their insights could eventually lead to new treatment approaches for ovarian cancer.”

Ayana Ruffin cancer cancer awareness cancer care Cancer Research Institute CRI Emory University fight against cancer Global fight against cancer OncoDaily Oncology tertiary lymphoid structures (TLS) TLS Tullia Bruno University of Pittsburgh

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity